Leading Seed-to-Sale Technology Provider Bolsters International Dominance With New Medical Cannabis Partnerships in Australia/Oceania Region
- LAUDERDALE, Fla., Oct. 8, 2018 /PRNewswire/ — Leading seed-to-sale cannabis software firm BioTrackTHC, a wholly owned subsidiary of Helix TCS Inc. (OTCQB: HLIX), continues its international expansion with new customers serving medical market cannabis producers in Australia and New Zealand.
The demand for medical marijuana in both Australia and New Zealand continues to rise as these strictly medicinal markets begin to lay the groundwork to establish safe and transparent patient access, making reliable and secure seed-to-sale tracking software essential to the industry’s success.
Headquartered in Fort Lauderdale, BioTrackTHC COO Dr. Moe Afaneh noted the company’s offices in Argentina, Colorado, Hawaii, Puerto Rico and Washington provide ideal positioning to service international businesses in the global cannabis market by spanning a variety of time zones and offering support during key business hours.
“BioTrackTHC can service businesses in countries halfway around the world because of our geographically distributed team,” Afaneh said. “With support spanning more than four time zones, we are confident in our ability to support the medical cannabis operators in Australia and New Zealand as they prepare to launch and scale their businesses.”
Because of the company’s background in pharmaceutical drug tracking, intersecting with its experience tracking cannabis in the U.S., the BioTrack team is able to provide unparalleled expertise to growing businesses in markets that treat cannabis more similarly to traditional prescription drugs. In addition to that blended experience, BioTrackTHC has a proven track record as a trusted choice for full-vertical tracking and dispensary point of sale for countries around the world and is able to support emerging international distribution.
For more information or to schedule an interview, please contact Shawna McGregor, Grasslands, at 917-971-7852 or firstname.lastname@example.org.
Bio-Tech Medical Software, Inc., through its BioTrackTHC division, develops and provides effective, cutting-edge technology solutions for the emerging medical and recreational cannabis industry. BioTrackTHC currently holds nine government contracts and operates across 31 states, Washington D.C., Puerto Rico, Australia, Canada, Jamaica and New Zealand. Bio-Tech Medical Software, Inc. is a wholly owned subsidiary of Helix TCS Inc. (OTCQB: HLIX). For more information, visit www.biotrack.com. Follow us on Facebook, Twitter and LinkedIn for important updates and relevant industry news.
About Helix TCS
Helix TCS, Inc. (OTCQB: HLIX) is a premier provider of integrated operating environment solutions for the legal cannabis industry. Helix provides a proprietary software suite and partnership platform to the legal cannabis industry, helping clients manage inventory and supply costs and bespoke monitoring and transport solutions. Helix provides clients in the legal cannabis industry high standard security operations, including transportation, armed and unarmed guarding, training, investigation, and special services.
Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: our ability to fund our operations and pay any outstanding debt; fluctuations in our financial results; general economic risks; the volatile nature of the market for our products and services and other factors that could impact our anticipated growth; our ability to manage our growth; changes in laws and regulations regarding the cannabis industry and service providers in the cannabis industry; reliance on key personnel; our ability to compete effectively; security and other risks associated with our business; intellectual property risks; and other risk factors set forth from time to time in our SEC filings. Helix TCS assumes no obligation and does not intend to update these forward-looking statements, except as required by law.
Grasslands: A Journalism-Minded Agency